Researchers Using AI: Don't Let Data Access Derail Clinical Breakthroughs

whitePaper | July 8, 2022

Before the onset of the coronavirus pandemic, forces at the federal level were in motion to transform the healthcare industry from a closed to a more open system.

whitePaper | May 16, 2023

The healthcare and life sciences communities have been undergoing a massive digital transformation since the COVID-19 pandemic. Everything from healthcare consumer expectations to government regulations are driving providers, payers, and pharmaceutical organizations to move aggressively toward digital interactions and transactions

whitePaper | September 22, 2022

Nearly lost in the dense fog of the pandemic is the overarching reality that healthcare is experiencing a tsunami of change.

whitePaper | March 10, 2023

The healthcare industry has widely acknowledged that the more we understand a patient’s unique healthcare journey the greater the chance we have at a positive health outcome. How does that concept tie in to real-word data (RWD)?

whitePaper | September 28, 2022

Specialty drugs span a wide range of disease states, from the more prevalent, yet complex, such as multiple sclerosis, to rare and orphan diseases, such as hereditary angioedema (HAE).

whitePaper | December 20, 2022

During the COVID-19 pandemic, drug overdose deaths have increased. At the same time, access to and utilization of substance use disorder treatment services have decreased.